1.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
2.
The Study on Relationship between the Expression of Plasminogen Activator, Plasminogen Activator Inhibitors and Invasion and Metastasis in Ovarian Carcinoma;
纤溶酶原激活因子及其抑制因子与卵巢癌的浸润转移
3.
Study of the Urokinase-type Plasminogen Activator Inhibited by Triplex-Forming Oligonucleotides in Rat Sertoli Cells;
三链形成寡核苷酸对大鼠Sertoli细胞尿激酶型纤溶酶原激活因子的反基因研究
4.
Study of the Roles and Mechanisms of Urokinase-type Plasminogen Activator in Promoting Male Fertility;
尿激酶型纤溶酶原激活因子多环节促雄性生育作用及相关机制探讨实验研究
5.
The invasion and metastasis of epithelial ovarian cancer be mediated by urokinase-type plasminogen activator in vitro
尿激酶型纤溶酶原激活因子介导的卵巢上皮癌细胞浸润转移体外的实验研究
6.
Expression of Plasminogen Activator、Plasminogen Activator Inhibitor in Polycystic Ovary Syndrome
纤溶酶原激活、抑制因子在PCOS卵巢中的表达
7.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
8.
The expression of plasminogen activator inhibitor 1 (PAI 1) gene in human astrocytomasG
人脑星形细胞瘤纤溶酶原激活抑制因子1基因表达研究
9.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
10.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
11.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
12.
Expression and Prognostic Significance of Nuclear Factor-kappaBp-65 and uPA in Cervical Carcinoma;
核转录因子-kBp65和尿激酶型纤溶酶原激活剂在人宫颈癌中的表达及预后意义
13.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
14.
Association of plasminogen activator inhibitor-1 gene promoter 4G/5G genotype polymorphism with gestational diabetes
纤溶酶原激活物抑制因子1基因启动子区4G/5G多态性与妊娠糖尿病的相关性研究
15.
The Changes of the Plasiminogen Activitor Inhibitor-1(PAI-1) in Patients with Coronary Heart Desease and It s Relationship to Clinical Factors;
冠心病患者血浆纤溶酶原激活剂抑制因子（PAI-1）的变化及其相关因素的研究
16.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
17.
recombinant human plasminogen
重组体人纤溶酶原激活质
18.
Establishment of Transgenic Goats for Human Tissue-type Plasminogen Activator with Sperm Mediated Gene Transfer Method;
利用精子载体方法研制人组织型纤溶酶原激活剂突变体转基因羊乳腺生物反应器